CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 36,841,081
- Share change
- -926,896
- Total reported value
- $245,069,950
- Price per share
- $6.65
- Number of holders
- 128
- Value change
- -$11,639,890
- Number of buys
- 56
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
2.4%
|
4,137,309
|
$34,464,000 | — | 30 Jun 2020 | |
| BVF INC/IL |
13F
|
Company |
1.8%
|
3,115,537
|
$25,952,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
2,652,335
|
$22,093,000 | — | 30 Jun 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
2,577,043
|
$21,467,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
2,350,671
|
$19,581,000 | — | 30 Jun 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
2,276,960
|
$18,967,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
2,195,649
|
$18,290,000 | — | 30 Jun 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.89%
|
1,514,476
|
$12,616,000 | — | 30 Jun 2020 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.85%
|
1,448,604
|
$12,067,000 | — | 30 Jun 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.61%
|
1,033,406
|
$8,608,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
0.49%
|
828,973
|
$6,906,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.43%
|
723,801
|
$6,029,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
708,889
|
$5,905,000 | — | 30 Jun 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.41%
|
686,674
|
$5,720,000 | — | 30 Jun 2020 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.39%
|
652,556
|
$5,435,000 | — | 30 Jun 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
570,604
|
$4,753,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
569,070
|
$4,741,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
541,800
|
$4,513,000 | — | 30 Jun 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.25%
|
423,542
|
$3,528,000 | — | 30 Jun 2020 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.22%
|
373,600
|
$3,113,000 | — | 30 Jun 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
365,097
|
$3,041,000 | — | 30 Jun 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
360,600
|
$3,004,000 | — | 30 Jun 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.21%
|
358,122
|
$2,983,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.19%
|
327,404
|
$2,728,000 | — | 30 Jun 2020 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
300,000
|
$2,499,000 | — | 30 Jun 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.17%
|
295,999
|
$2,465,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
277,845
|
$2,315,000 | — | 30 Jun 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.15%
|
253,700
|
$2,113,000 | — | 30 Jun 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.15%
|
251,475
|
$2,095,000 | — | 30 Jun 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.15%
|
246,169
|
$2,051,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
241,127
|
$2,009,000 | — | 30 Jun 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.12%
|
203,735
|
$1,697,000 | — | 30 Jun 2020 | |
| Man Group plc |
13F
|
Company |
0.11%
|
194,412
|
$1,619,000 | — | 30 Jun 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
190,325
|
$1,585,000 | — | 30 Jun 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.11%
|
188,000
|
$1,566,000 | — | 30 Jun 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.11%
|
187,461
|
$1,562,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
181,084
|
$1,508,000 | — | 30 Jun 2020 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.09%
|
151,500
|
$1,262,000 | — | 30 Jun 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
148,952
|
$1,241,000 | — | 30 Jun 2020 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.08%
|
133,177
|
$1,109,000 | — | 30 Jun 2020 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.08%
|
132,616
|
$1,105,000 | — | 30 Jun 2020 | |
| Trexquant Investment LP |
13F
|
Company |
0.08%
|
128,274
|
$1,069,000 | — | 30 Jun 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
115,664
|
$963,000 | — | 30 Jun 2020 | |
| PDT Partners, LLC |
13F
|
Company |
0.07%
|
112,519
|
$937,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
106,022
|
$883,000 | — | 30 Jun 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.06%
|
103,180
|
$857,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
100,609
|
$838,000 | — | 30 Jun 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
100,012
|
$833,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
99,559
|
$828,000 | — | 30 Jun 2020 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
96,164
|
$801,000 | — | 30 Jun 2020 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q3 2020
As of 30 Sep 2020,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,841,081 shares.
The largest 10 holders included
BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, RTW INVESTMENTS, LP, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
133
Q3 2020 holders
128
Holder diff
-5
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.